Top Vaccines companies in Israel by Debt to Equity Ratio
This ranking features the top 5 Vaccines companies in Israel ranked by Debt to Equity Ratio, averaging a Debt to Equity Ratio of 0.29, for February 07, 2025.
Israel
Vaccines
Debt to Equity Ratio
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
0.88
|
Dec. 31, 2023 | USD 0.01 | -3.84% |
|
Israel |
|
| 2 |
0.49
|
Dec. 31, 2023 | USD 0.11 | 3.21% |
|
Israel |
|
| 3 |
0.04
|
Dec. 31, 2023 | USD 6.96 | 3.55% |
|
Israel |
|
| 4 |
0.02
|
Dec. 31, 2023 | USD 2.38 | 4.02% |
|
Israel |
|
| 5 |
0.01
|
Dec. 31, 2023 | USD 0.02 | -4.22% |
|
Israel |
Frequently Asked Questions
-
Which Vaccines company in Israel has the highest Debt to Equity Ratio ?
The Vaccines company in Israel with the highest Debt to Equity Ratio is BioLineRx Ltd. (Tel Aviv Stock Exchange: BLRX.TA) at 0.88.
-
Which Vaccines company in Israel has the lowest Debt to Equity Ratio ?
The Vaccines company in Israel with the lowest Debt to Equity Ratio is Purple Biotech Ltd. (Tel Aviv Stock Exchange: PPBT.TA) at 0.01.
-
What are the top 10 Vaccines companies in Israel by Debt to Equity Ratio ?
The top 10 Vaccines companies in Israel by Debt to Equity Ratio are BioLineRx Ltd., Tikun Olam-Cannbit Pharmaceuticals Ltd, Kamada Ltd., Compugen Ltd. and Purple Biotech Ltd..
-
What are the bottom 10 Vaccines companies in Israel by Debt to Equity Ratio ?
The bottom 10 Vaccines companies in Israel by Debt to Equity Ratio are Purple Biotech Ltd., Compugen Ltd., Kamada Ltd., Tikun Olam-Cannbit Pharmaceuticals Ltd and BioLineRx Ltd..
